MGI Pharma to evaluate strategic options |
|
|
|
Published
:
Thu, 29 Nov 2007 15:24
|
BOSTON (Thomson Financial) - MGI Pharma Inc. Thursday said its board has authorized management to explore strategic alternatives.To that end, the company has retained Lehman Brothers to serve as its financial advisor.MGI Pharma said it will not disclose further information regarding the status of its evaluation until the process has been completed.Shares of the Bloomington, Minn.-based biopharmaceutical company focused in oncology and acute care closed Wednesday at $29.48.Casey Logancl/mbCOPYRIGHTCopyright Thomson Financial News Limited 2007. All rights reserved.The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
1796.52 |
-49.20 (
-2.70 %)
|
| SYMBOL (
2009-07-03 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
1625.00 |
+15.00 (
0.93 %)
|
| SYMBOL (
2009-07-02 )
|
| LAST |
CHANGE
|
|
INTEL CP
(
4:00pm ) |
|
16.72 |
-0.32 (
-1.90 %)
|
| SYMBOL (
2009-07-02 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Suffolk Life says exploring strategic options for co 